Uprosertib
N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methylpyrazol-5-yl)furan-2-carboxamide
Molecular Identity
Uprosertib
N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methylpyrazol-5-yl)furan-2-carboxamide
PubChem CID: 51042438
2D Structure
Properties
C18H16Cl2F2N4O2
Molecular Formula
429.20
Molecular Weight
g/mol
428.0618
Exact Mass
Da
3.4
XLogP
Drug-like (Lipinski: < 5)
86.1
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
550
Complexity
SMILES
Canonical SMILES
SMILES: CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)ClIsomeric SMILES
SMILES: CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)ClSynonyms(20)
Uprosertib1047634-65-0GSK2141795GSK-2141795GSK2141795CZXM835LQ5EAkt inhibitor gsk2141795Akt inhibitor gsk-2141795Uprosertib [USAN:INN]GSK-2141795CUprosertib [USAN]UPROSERTIB [INN]UPROSERTIB [WHO-DD]N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide2-Furancarboxamide, N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Uprosertib
Loading drug network...